| Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications CK Liu C, Zhang L, Liu H J Control Release, 17-26, 2017 | 593 | 2017 |
| Enzyme-Responsive Polymeric Micelles of Cabazitaxel for Prostate Cancer Targeted Therapy KC Ashutosh Barve, Akshay Jain, Hao Liu, Zhen Zhao Acta Biomaterialia, 2020 | 124 | 2020 |
| Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy KC Hao Liu, Zhen Zhao, Li Zhang, Yuanke Li, Akshay Jain, Ashutosh Barve, Wei ... Journal for ImmunoTherapy of Cancer, 2019 | 108 | 2019 |
| Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis CK Chen Z, Jain A, Liu H, Zhao Z Journal of Pharmacology and Experimental Therapeutics 370 (3), 2019 | 94 | 2019 |
| Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer KC Zhen Zhao, Yuanke Li, Hao Liu, Akshay Jain, Pratikkumar Vinodchandra Patel Science Advances 6, 2020 | 67 | 2020 |
| Development of a Peptide-Modified siRNA Nanocomplex for Hepatic Stellate Cells KC Zhen Zhao, Yuanke Li, Akshay Jain, Zhijin Chen, Hao Liu, Wei Jin Nanomedicine: Nanotechnology, Biology and Medicine, 2017 | 54* | 2017 |
| Discovery of PSMA-Specific Peptide Ligands for Targeted Drug Delivery KC Wei Jin, Bin Qin, Zhijin Chen, Hao Liu, Ashutosh Barve International Journal of Pharmaceutics, 2016 | 52 | 2016 |
| Development of a biocompatible copolymer nanocomplex to deliver VEGF siRNA for triple negative breast cancer Z Zhao, Y Li, R Shukla, H Liu, A Jain, A Barve, K Cheng Theranostics 9 (15), 4508, 2019 | 49 | 2019 |
| Discovery of aptamer ligands for hepatic stellate cells using SELEX Z Chen, H Liu, A Jain, L Zhang, C Liu, K Cheng Theranostics 7 (12), 2982, 2017 | 46 | 2017 |
| Discovery of Peptide ligands for hepatic stellate cells using phage display. CK Chen Z, Jin W, Liu H, Zhao Z Mol Pharm. 12 (6), 2180-2188, 2015 | 46 | 2015 |
| Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma KC Yuanke Li, Zhen Zhao, Hao Liu, John Peter Fetse, Akshay Jain, Chien-Yu Lin ACS Appl. Mater. Interfaces, 2019 | 45 | 2019 |
| An enzyme-responsive conjugate improves the delivery of a PI3K inhibitor to prostate cancer KC Ashutosh Barve, Akshay Jain, Hao Liu, Wei Jin Nanomedicine: Nanotechnology, Biology and Medicine 12 (8), 2373-2381, 2016 | 37 | 2016 |
| Discovery of cyclic peptide inhibitors targeting PD-L1 for cancer immunotherapy J Fetse, Z Zhao, H Liu, UF Mamani, B Mustafa, P Adhikary, M Ibrahim, ... Journal of medicinal chemistry 65 (18), 12002-12013, 2022 | 30 | 2022 |
| Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay SLSKSSRMCDKXJHLST Stern ACS Pharmacology & Translational Science, 2020 | 29 | 2020 |
| Targeted delivery of an siRNA/PNA hybrid nanocomplex reverses carbon tetrachloride‐induced liver fibrosis A Jain, A Barve, Z Zhao, JP Fetse, H Liu, Y Li, K Cheng Advanced therapeutics 2 (8), 1900046, 2019 | 25 | 2019 |
| Silencing of α-complex protein-2 reverses alcohol-and cytokine-induced fibrogenesis in hepatic stellate cells KC H Liu, Z Chen, W Jin, A Barve, YJY Wan Liver Research, 2017 | 20 | 2017 |
| Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy GLKC Hao Liu, Yanli Liu, Zhen Zhao, Yuanke Li, Bahaa Mustafa, Zhijin Chen ... Front. Immunol., 2022 | 13 | 2022 |
| Noncovalent Attachment of Chemical Moieties to siRNA Using Peptide Nucleic Acid As a Complementary Linker KC W Jin, A Jain, H Liu, Z Zhao ACS Applied Bio Materials, 2018 | 4 | 2018 |
| assessing the immunogenicity risk of salmon calcitonin peptide impurities using in silico and in vitro methods | | 2024 |
| Polypeptides And Compositions Comprising The Same K Cheng, H Liu, J Fetse, UF Mamani US Patent App. 17/507,301, 2022 | | 2022 |
Akshay JainGlaxoSmithKlinegsk.com의 이메일 확인됨
